Virolfi 450 mg (Valganciclovir) – Informational Overview for CMV Care | Oddway

Virolfi 450 mg functions as an antiviral drug which doctors use to treat and prevent cytomegalovirus (CMV) infections that affect patients with weakened immune systems including organ-transplant recipients and people who have HIV. The drug contains valganciclovir which transforms into its active form to block the process of viral DNA replication.

Therapeutic Use

Doctors frequently prescribe virolfi tablets to treat CMV retinitis and to provide CMV prophylaxis for patients who have undergone transplantation. Valganciclovir 450 mg enables patients to take their medication through oral delivery system which doctors have verified through clinical testing when patients follow their medical guidelines.

B2B & Supply Information

Oddway International supplies Virolfi for hospitals, pharmacies, clinics, and global distributors. The company provides international partners with options to place bulk orders, use third-party manufacturing services, and receive export support.

Contact Details

For pricing, documentation, and B2B inquiries, contact Oddway International through their official website or authorized sales channels.